Website Page

The IASLC 2024 Hot Topic in Basic & Translational Science: Tolerance & Resistance to Targeted Therapy in NSCLC (HTTR 2024) offers your organization multiple opportunities to engage with basic scientists, translational researchers, and clinicians working to advance the understanding and treatment of non-small cell lung cancer.

For information regarding promotion & advertising, symposia and exhibit opportunities, please contact:

Stay Connected


© 2024 International Association for the Study of Lung Cancer - IASLC HTTR 2024